A devastating blow for the Braves! Jurickson Profar is reportedly facing a monumental 162-game ban from Major League Baseball following what's believed to be his second positive test for a performance-enhancing drug. This news, initially reported by ESPN and confirmed by an Associated Press source, could sideline the All-Star outfielder for the entire season.
But here's where it gets complicated: Profar isn't taking this lying down. Sources close to the situation indicate that Profar plans to have the players' association initiate a grievance. This means his case will be brought before baseball's independent arbitrator, Martin F. Scheinman, for an appeal. It's important to note that under MLB's drug policy, any appeal for a second offense would only commence after a suspension has been officially announced. This process is still unfolding, and no official announcement has been made yet.
This isn't Profar's first dance with the league's drug policy. He was previously suspended for 80 games on March 31st of last year after testing positive for Chorionic Gonadotrophin (hCG). For those new to this, hCG is a hormone that can boost testosterone production, which is why it's on the banned substance list. At the time, Profar expressed remorse, stating, "I would never willingly take a banned substance, but I take full responsibility and accept MLB’s decision." His agent, Dan Lozano, has not yet responded to requests for comment on this latest development.
And this is the part most people miss: While Profar's return from his previous suspension was marked by a home run on July 2nd, his performance that season saw him hit .245 with 14 homers and 43 RBIs. However, he truly shined in 2024, posting career-best numbers with a .280 batting average, 24 homers, 85 RBIs, and an impressive .839 OPS. He had also mentioned undergoing sports hernia surgery in November, with a recovery period of about six weeks. He's been active in spring training, showing promising signs in limited at-bats.
The implications of this potential suspension are significant. Not only would Profar be ineligible for the postseason, but he would also forfeit his $15 million salary for the current year. This comes on top of the $42 million, three-year contract he signed through 2027. Remember, he already lost half of his $12 million salary in 2025 due to his initial suspension. This makes him the seventh player to face a 162-game ban for a second PED infraction. Other notable players who have received similar suspensions include Jenrry Mejia, Marlon Byrd, Cody Stanley, Francis Martes, Robinson Canó, and J.C. Mejia. It's worth noting that J.C. Mejia received a lifetime ban in 2016 after a third positive test, a severe penalty that hasn't been handed out since the current drug testing program began in 2004.
This situation also creates ripples throughout the Braves' roster. With Profar having been slated to be the primary designated hitter, the team will need to find alternative solutions. The return of catcher Sean Murphy from injury in May, along with players like Drake Baldwin, Eli White, and even Dominic Smith (who recently signed a minor league deal), could help fill the void. The Braves are also managing other injuries, including the absence of projected starting shortstop Ha-seong Kim.
Now, let's talk about the fairness of these penalties. Is a 162-game suspension, essentially an entire season, a just punishment for a second positive test, especially when considering the player's potential for rehabilitation and contribution to the game? Or does the integrity of the sport demand such strict consequences to deter others? What are your thoughts on this? Let us know in the comments below!
